Plasma proteomic studies have found that LCAT, GPX3, and leukotriene b4 can serve as potential biomarkers for thyroid cancer (16), and serum ISG15 and PLXNB2 can also serve as potential biomarkers (17). The gene discussed is PLXNB2; the disease is thyroid gland carcinoma.